Targeting poor circulatory conditions

ULTRAVIOLET BLOOD IRRADIATION is also known as photoluminescence, or extra-corporeal photophoresis. It is a procedure where the patient’s blood is extracted and exposed to ultraviolet light. The infused blood provides the following benefits: stimulation of the immune system, increased microcirculation and oxygenation of tissues; in addition, irradiated blood has powerful antiviral, antibacterial and anti inflammatory properties, and can help reduce the size and inflammatory activity of large tumors.

Applying ultraviolet rays directly to a patient’s blood was originally conceived as a method of utilizing the bactericidal properties of the rays in the treatment of blood stream infections. Current developments in the use of UV have led to a well controlled procedure that produces excellent results with virtually no side effects. Proper instrumentation and training provide clinical results in an inexpensive, expeditious and reliable procedure.

Since this procedure involves no kidney damage whatsoever, diabetic chronic circulatory problems and older people can easily be treated. Peripheral arteriosclerosis and even gangrene can be treated as well.

Ultraviolet Blood Irradiation targets poor circulatory conditions, where blood flow is poor and more aggressive techniques, such as chelation or even vascular manipulation, could imply a health risk to the patient. Older patients with vascular conditions and lower immune performance are also good candidates for this treatment.

Ultraviolet irradiation of the blood is a valuable treatment tool that may prove to be an important alternative in the treatment and management of difficult chronic infectious, inflammatory processes and a number of degenerative conditions, where higher oxygenation levels and better immune performance are required.

Irradiated blood has powerful antiviral, antibacterial and anti inflammatory properties and can help reduce the size and inflammatory activity of large tumors.

Comprehensive cancer and chronic inflammatory degenerative disease treatments are available for (but not restricted to):